Get a reply from this employer
Your resume and cover letter, tailored to exactly what they’re hiring for.
Neurocrine Biosciences is seeking a Senior Director, Global Managed Access Programs to lead strategic and operational efforts for MAP design and execution worldwide. You will collaborate across Medical Affairs, Lifecycle Management, Market Access, Regulatory, and Supply Chain to ensure compliant access pathways for patients in regions without traditional commercial access.
The role requires deep regulatory and operational expertise in unlicensed and post-trial access, with a focus on scalable
Neurocrine Biosciences is a leading biopharmaceutical company with a simple purpose: to relieve suffering for people with great needs. We are dedicated to discovering, developing and commercializing life-changing treatments for patients with under-addressed neurological, psychiatric, endocrine and immunological disorders. The company's diverse portfolio includes FDA-approved treatments for tardive dyskinesia, chorea associated with Huntington's disease, classic congenital adrenal hyperplasia, hyperphagia in Prader-Willi syndrome, endometriosis* and uterine fibroids*, as well as a robust pipeline including multiple compounds in mid- to late-phase clinical development across our core therapeutic areas. For more than three decades, we have applied our unique insight into neuroscience and the interconnections between brain and body systems to treat complex conditions. We relentlessly pursue medicines to ease the burden of debilitating diseases and disorders, because you deserve brave science. For more information, visit neurocrine.com, and follow the company on LinkedIn, X, Facebook and YouTube. (*in collaboration with AbbVie) At Neurocrine, strong leadership drives both business results and team success. We look for leaders who think strategically, anticipate what's ahead and set clear direction, while building and empowering high-performing teams. Successful leaders foster an environment where people are motivated to do their best work and deliver meaningful, measurable impact through sound decision-making and accountability.
The Senior Director, Global Managed Access Programs, Strategy & Operations will provide strategic and operational leadership for the development and execution of Neurocrine's global Managed Access Programs (MAP) (eg, early access, post-trial access, name patient sales, etc.), enabling appropriate access to Neurocrine medicines for patients in countries where traditional commercial access is not yet available or is not planned. This individual will serve as the enterprise leader for managed access strategy and execution, bringing together Medical Affairs, Lifecycle Management, Market Access, Commercial, Regulatory Affairs, Pharmacovigilance, Quality, Technical Operations/Supply Chain, Legal, Compliance, Finance and other partners to determine where and how MAP should be implemented across the Neurocrine portfolio. The Senior Director will be accountable for translating asset and lifecycle strategy into scalable, compliant and operationally executable access pathways across countries. The Senior Director will support managed access planning across the product lifecycle (eg, Early/Expanded Access Programs, Single/Named Patient Access, cohort programs, Post-Trial Access, and other pre- and post-approval access pathways, as appropriate). The role will lead the selection, oversight and governance of external partners responsible for program administration, regulatory coordination, distribution and other access services, while ensuring Neurocrine maintains appropriate strategic oversight, decision-making and accountability. This role requires deep expertise in the complex regulatory, operational, supply and access considerations associated with providing medicines outside traditional commercial channels. The successful candidate will combine strategic thinking with strong operational leadership and will be able to navigate highly matrixed, time-sensitive situations where patient need, regulatory requirements, supply considerations and long-term asset strategy intersect.
Lead the end-to-end design and operationalization of MAPs, establishing clear implementation plans, timelines, decision points, accountabilities and escalation pathways. Lead or facilitate cross-functional MAP working groups to develop program-specific access strategies including exit and transition strategy. Establish scalable processes for physician requests, patient eligibility assessment, program enrollment, product ordering and fulfillment, program renewals and discontinuation or transition. Partner with Regulatory Affairs to understand and navigate country-specific requirements for unlicensed or investigational medicine access, importation, labeling, documentation and regulatory submissions. Partner closely with Technical Operations and Supply Chain to develop demand forecasts, assess supply feasibility, establish appropriate distribution models and ensure reliable product availability. Ensure appropriate integration of Pharmacovigilance, Quality, product complaint management, data privacy and other compliance requirements into each program. Anticipate operational risks and emerging patient access issues and establish mitigation and contingency plans to ensure continuity of treatment wherever appropriate.
Lead the strategy, selection and governance of external MAP partners, distributors and other service providers. Establish clear roles, responsibilities, service-level expectations, decision rights, escalation pathways and performance metrics with external partners. Maintain senior-level relationships with key strategic vendors and hold partners accountable for program quality, responsiveness, regulatory compliance, patient and HCP experience, and operational performance. Assess the external access landscape and recommend new capabilities, partnerships, technologies or operating models that improve Neurocrine's ability to provide compliant and efficient patient access globally.
Establish and lead cross-functional governance for MAP, ensuring appropriate representation and decision-making across Medical Affairs, Lifecycle Management, Regulatory, Market Access, Commercial, Supply Chain, Quality, Pharmacovigilance, Legal, Compliance and Finance. Define enterprise policies, standards, SOPs, decision frameworks and governance processes for NPP initiation, operation, expansion and discontinuation. Establish clear processes for assessing new country or patient access requests, including defined decision criteria and escalation pathways for complex or time-sensitive situations. Serve as the internal subject matter expert for MAP and advise senior leadership and asset teams on global access options, risks, trade-offs and recommendations. Build organizational understanding of MAP requirements and provide education and training to cross-functional teams on appropriate processes, roles and responsibilities.
Partner with Market Access, Finance and Commercial teams to evaluate appropriate models for funded, reimbursed, for-charge or other permitted access pathways based on local regulatory and market requirements. Ensure program strategy considers potential implications for future pricing, reimbursement, HTA, commercial launch and geographic expansion decisions. Develop transition strategies as products move from early access or unlicensed access to approved and reimbursed commercial access, with particular attention to continuity of treatment for patients already receiving therapy. Develop strategies for countries where Neurocrine may not establish a traditional commercial presence but where a sustainable mechanism for ongoing patient access may be appropriate.
Establish program KPIs and dashboards that provide leadership with visibility into patient demand, geography, time to access, program performance, supply requirements, costs, vendor performance and emerging risks. Lead program budget development, forecasting and ongoing financial oversight. Analyze program trends and access barriers to identify opportunities to improve patient access, operational efficiency and long-term portfolio planning. In partnership with Medical Affairs, HEOR, Regulatory and other appropriate functions, evaluate opportunities for compliant collection and use of data generated through access programs where scientifically appropriate and permitted by local regulations. Monitor the evolving global regulatory and policy environment for Named Patient, Expanded Access, Compassionate Use and other Managed Access pathways and recommend changes to Neurocrine's strategy and operating model. Drive continuous improvement and harmonization of processes across programs and geographies as Neurocrine's global portfolio and footprint expand.
#LI-OS1 Neurocrine Biosciences is an EEO/Disability/Vets employer. We are committed to building a workplace of belonging, respect, and empowerment, and we recognize there are a variety of ways to meet our requirements. We are looking for the best candidate for the job and encourage you to apply even if your experience or qualifications don't line up to exactly what we have outlined in the job description. We are a top place to work. Neurocrine Biosciences was named one of the FORTUNE Best Workplaces in Biopharma™ 2026. We were also named a Great Place to Work® Certified company. © 2026 © 2025 Fortune Media IP Limited. All rights reserved. Used under license.
Come join our team during this exciting time of growth and opportunities!